For drug developers, the program serves as a real-time notification system that conducts a Canada-wide scan, alerting you to recruitment opportunities as well as competitive roadblocks. This gives you an immediate and accurate assessment of Canada’s enrollment potential.

For sites it serves as the link to cutting-edge oncology clinical trials in Canada that could potentially extend the lives of their patients while allowing them to contribute to the development of new treatment options.